广发纳斯达克生物科技人民币(001092)
动态评分： 5.28分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2019-12-31 | ASND | Ascendis Pharma AS ADR | 104.33 | 0.65% |
| 2019-12-31 | EXEL | 伊克力西斯 | 103.44 | 0.64% |
| 2019-12-31 | BLUE | 蓝鸟生物 | 87.42 | 0.54% |
| 2019-12-31 | RETA | Reata Pharmaceuticals Inc-A | 82.86 | 0.52% |
| 2019-12-31 | GBT | 全球血液疗法 | 81.79 | 0.51% |
| 2019-12-31 | RGEN | Repligen Corp | 80.34 | 0.5% |
| 2019-12-31 | CBPO | 泰邦生物 | 76.97 | 0.48% |
| 2019-12-31 | UTHR | 联合治疗 | 76.25 | 0.47% |
| 2019-12-31 | ICPT | Intercept Pharmaceuticals Inc | 73.14 | 0.46% |
| 2019-12-31 | NKTR | 内克塔治疗 | 73.21 | 0.46% |
| 2019-12-31 | FGEN | FibroGen Inc | 71.06 | 0.44% |
| 2019-12-31 | IMMU | Immunomedics Inc | 70.07 | 0.44% |
| 2019-12-31 | BPMC | Blueprint Medicines Corp | 69.8 | 0.43% |
| 2019-12-31 | SAGE | Sage Therapeutics Inc | 66.83 | 0.42% |
| 2019-12-31 | GRFS | 基立福 | 66.62 | 0.41% |
| 2019-12-31 | ALKS | 阿尔凯默斯 | 62.6 | 0.39% |
| 2019-12-31 | MEDP | Medpace Holdings Inc | 59.46 | 0.37% |
| 2019-12-31 | CRSP | CRISPR Therapeutics AG | 57.19 | 0.36% |
| 2019-12-31 | MYOK | MyoKardia Inc | 57.56 | 0.36% |
| 2019-12-31 | GWPH | GW Pharmaceuticals plc ADR | 55.44 | 0.35% |
公告&资料
